Sigma Launches Human Plasma Depletion Technology for Proteomics and Human Disease Biomarker Discovery

Product News   Jan 26, 2006

 
Sigma Launches Human Plasma Depletion Technology for Proteomics and Human Disease Biomarker Discovery
 
 
FURTHER INFORMATION
 
 
 

Related Product News

Cambridge Research Biochemicals to Support Preclinical Study on Treatment for Vision-Damaging Eye Disease

Product News

Under a new contract, Cambridge Research Biochemicals® will support evaluation of a potential new treatment approach for Fuchs Dystrophy, a disease that typically occurs in middle age and may cause a gradual loss of vision.

READ MORE

GE Increases Cell Culture Media Production Capacity by Tenfold

Product News

GE Healthcare Life Sciences is increasing the annual production capacity of powdered cell culture media by tenfold in its facility in Pasching, Austria.

READ MORE

Zymeworks and Daiichi Sankyo Expand Immuno-Oncology Collaboration Focused on Bispecific Antibodies

Product News

Two additional licenses granted; upfront payment of US$18 million; total potential transaction value of up to US$484.7 million.

READ MORE

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy